Doctors On the Take May Go to Prison
Like their benefactors–drug manufacturers–who violate the law, doctors will be prosecuted in court by the federal government.
Like their benefactors–drug manufacturers–who violate the law, doctors will be prosecuted in court by the federal government.
"Whatever powers the Constitution has granted our government, involuntary mind control is not one of them, absent extraordinary circumstances." 1979, Judge Joseph L. Tauro
“Bitter Pill” by Ben Wallace-Wells in the current issue of Rolling Stone is an excellent, informative, in-depth article providing an overview into the pharmaceutical industry’s immensely successful—albeit illegal—aggressive marketing tactics, for selling a particularly unsafe, dangerous class of drugs—the antipsychotics, Zyprexa in particular.
This has the potential for restoring integrity to medicine by providing doctors and the public with impartial risk / benefit information about existing treatments devoid of commercial bias.
These illegal practices are the secret behind this toxic drug–Zyprexa– becoming a blockbuster seller.
“No general counsel or CEO wants to have to explain to his board why the company's name is appearing on the front page of a news article in a scandal…"
To gain insight into how a pharmaceutical giant is revving up itsr troops to lobby Congress against the legislation. See Pfizer CEO’s directive to the entire staff exhorting them to mobilize and lobby Congress to vote against drug price controls. http://www.pfizerfactfiction.com/mma/flash.html
Two ground breaking legal actions in Texas to rein in out of control psychotropic drug prescribing will have nationwide reverberations.
U.S. State Attorneys General should investigate the fraudulent marketing of the atypical neuroleptic drugs-and FDA's role in helping conceal the truth.
The New York Times reports: "For big drug companies, the new Medicare prescription benefit is proving to be a financial windfall larger than even the most optimistic Wall Street analysts had predicted."
AHRP Speaks Out AHRP Press Briefing 9/14/04: Antidepressants & suicide-related risks for children Open Letter to NIMH re Prozac & Concealed Suicide Attempts Open Letter to Officials at NIMH AHRP Briefing 2/2/04: Scientists present suicide evidence Conflicts of Interest policy – New York Times Phase I Drug Trials Used Foster…
FDA Smoke & Mirrors Musical Chairs Wed, 16 Feb 2005 Amidst widespread public criticism of the FDA’s role as facilitators in the marketing of lethal drugs that killed thousands of people, the Administration made several announcements incorporating terminology (such as: “we’re in an era of openness” “transparency”). But politically correct…